Scrip Asia 100 – 2020 Pharmaceutical Sales ($M)
|
Rank
|
Company
|
2020 Pharma Sales ($m)
|
Change from 2019 ($ Basis)
|
1
|
Takeda
|
29961
|
-1%
|
2
|
Astellas
|
11707
|
-2%
|
3
|
CSL
|
9151
|
7%
|
4
|
Daiichi Sankyo
|
9018
|
0%
|
5
|
Otsuka Pharmaceutical
|
8949
|
6%
|
6
|
Eisai
|
6052
|
-5%
|
7
|
Sumitomo Dainippon Pharma
|
4834
|
9%
|
8
|
Sun Pharmaceutical
|
4522
|
-3%
|
9
|
Jiangsu Hengrui Medicine Co. Ltd.
|
4022
|
21%
|
10
|
Asahi Kasei Pharma
|
3822
|
23%
|
11
|
Mitsubishi Tanabe Pharma
|
3540
|
2%
|
12
|
Shanghai Pharmaceutical Group Co., Ltd.
|
3443
|
1%
|
13
|
Sino Biopharmaceutical
|
3429
|
0%
|
14
|
CSPC Pharmaceutical Group Ltd.
|
3158
|
16%
|
15
|
Shanghai Fosun Pharmaceutical Group
|
3153
|
1%
|
16
|
Aurobindo
|
3118
|
1%
|
17
|
Kyowa Hakko Kirin
|
2983
|
3%
|
18
|
Cipla
|
2563
|
6%
|
19
|
Dr Reddy's
|
2561
|
4%
|
20
|
Sichuan Kelun Pharmaceutical
|
2387
|
-5%
|
21
|
Shandong Buchang Pharmaceuticals Co., Ltd.
|
2321
|
15%
|
22
|
Santen
|
2199
|
7%
|
23
|
DaShenLin Pharmaceutical Group Co., Ltd.
|
2115
|
33%
|
24
|
Lupin
|
2047
|
-5%
|
25
|
Zydus Cadila (Cadila Healthcare)
|
2044
|
15%
|
26
|
Ono
|
2010
|
9%
|
27
|
Meiji Holdings
|
1814
|
-3%
|
28
|
Nichi-Iko
|
1763
|
-2%
|
29
|
Sawai
|
1754
|
1%
|
30
|
Celltrion
|
1570
|
62%
|
31
|
Harbin Pharmaceutical Group Co., Ltd.
|
1564
|
-7%
|
32
|
Livzon Pharmaceutical Group
|
1525
|
14%
|
33
|
Glenmark Pharmaceuticals
|
1477
|
4%
|
34
|
Towa
|
1451
|
43%
|
35
|
Teijin Pharma
|
1393
|
-1%
|
36
|
GC Pharma
|
1277
|
9%
|
37
|
Shijiazhuang Yiling Pharmaceutical Co.,Ltd
|
1273
|
55%
|
38
|
Hansoh Pharmaceutical
|
1260
|
-1%
|
39
|
CR Double-Crane Pharmaceuticals Co., Ltd
|
1233
|
-7%
|
40
|
KPC Pharmaceutical Inc.
|
1119
|
-3%
|
41
|
Chong Kun Dang
|
1106
|
19%
|
42
|
Torrent Pharmaceuticals
|
1080
|
3%
|
43
|
Hisamitsu
|
1073
|
-20%
|
44
|
Zhejiang Medicine Co., Ltd.
|
1062
|
6%
|
45
|
Kwang-Dong Pharmaceutical
|
1056
|
-1%
|
46
|
Nippon Shinyaku
|
998
|
27%
|
47
|
Shionogi
|
997
|
-32%
|
48
|
Samsung BioLogics
|
989
|
64%
|
49
|
Kyorin
|
964
|
-4%
|
50
|
Biocon
|
959
|
3%
|
51
|
Mochida
|
954
|
-5%
|
52
|
Zhejiang Huahai Pharmaceutical Co., Ltd.
|
940
|
23%
|
53
|
Hanmi Pharm
|
913
|
-3%
|
54
|
Daewoong Pharmaceutical
|
896
|
-4%
|
55
|
Zhejiang Conba Pharmaceutical Co., Ltd.
|
857
|
-11%
|
56
|
Maruho
|
833
|
2%
|
57
|
Jubilant Life Sciences (now Jubilant Pharmova)
|
826
|
-32%
|
58
|
3SBio
|
805
|
5%
|
59
|
Luye Pharma Group Ltd.
|
803
|
-13%
|
60
|
Piramal Healthcare
|
780
|
2%
|
61
|
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
|
773
|
17%
|
62
|
Japan Tobacco
|
740
|
-9%
|
63
|
Hualan Biological Engineering, Inc.
|
728
|
38%
|
64
|
Alembic
|
728
|
11%
|
65
|
PT Kimia Farma
|
689
|
4%
|
66
|
Dong-A Socio Holdings
|
665
|
3%
|
67
|
Kaken
|
622
|
-15%
|
68
|
Shandong Lukang Pharmaceutical Co., Ltd.
|
610
|
14%
|
69
|
Laurus Labs Ltd.
|
609
|
64%
|
70
|
Yestar Healthcare Holdings Company Limited
|
595
|
-17%
|
71
|
Jeil Pharmaceutical
|
587
|
2%
|
72
|
SSY Group Limited
|
549
|
-8%
|
73
|
Maccura Biotechnology Co., Ltd.
|
537
|
397%
|
74
|
Kissei
|
528
|
4%
|
75
|
Zhuzhou Qianjin Pharmaceutical Co., Ltd.
|
526
|
5%
|
76
|
China Biologic Products Inc.
|
524
|
4%
|
77
|
Guangxi Wuzhou Pharmaceutical Group Co. Ltd.
|
523
|
-3%
|
78
|
Taisho
|
516
|
-18%
|
79
|
Sinovac Biotech Ltd.
|
511
|
108%
|
80
|
HK inno. N (formerly CJ Healthcare)
|
508
|
0
|
81
|
Toray Industries
|
496
|
1%
|
82
|
Jiangsu NHWA Pharmaceutical Co., Ltd.
|
487
|
-17%
|
83
|
Japan Lifeline Co., Ltd.
|
481
|
386%
|
84
|
Boryung
|
477
|
6%
|
85
|
Il-Dong Pharm
|
477
|
90%
|
86
|
Dongkook Pharm
|
475
|
15%
|
87
|
Nippon Kayaku
|
473
|
8%
|
88
|
JW Pharmaceutical Corporation
|
465
|
6%
|
89
|
Strides Pharma
|
448
|
12%
|
90
|
Xiangxue Pharmaceutical Co., Ltd.
|
445
|
12%
|
91
|
Harbin Gloria Pharmaceuticals Co., Ltd.
|
443
|
-38%
|
92
|
Jiangsu Kanion Pharmaceutical Co Ltd
|
440
|
-32%
|
93
|
Takara Bio Inc.
|
432
|
32%
|
94
|
Walvax Biotechnology Co., Ltd.
|
426
|
166%
|
95
|
Topcon Corp.
|
413
|
35%
|
96
|
Gansu Duyiwei Biological Pharmaceutical Co., Ltd.
|
407
|
-23%
|
97
|
Zheijiang JingXin Pharmaceutical Co., Ltd.
|
406
|
488%
|
98
|
Mega Lifesciences Public Co. Ltd.
|
404
|
13%
|
99
|
Shanghai RAAS Blood Products Co., Ltd.
|
400
|
9%
|
100
|
Torii
|
391
|
-1%
|